Philip Morris Intl (NYSE:PM) 주식

Philip Morris Intl

Created from the international operations of Altria in 2008, Philip Morris International sells cigarettes and reduced-risk products, including heatsticks, vapes, and oral nicotine offerings primarily outside of the US. With the 2023 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches primarily in the US and Scandinavia, PMI has not only diversified away from smokeable products but also gained a toehold into the US to sell its iQOS heated tobacco product.

Large Cap

News

Movers

Trading Ideas

CPRI

GRAB

MSTR

TSLA

이들 10개 대형주는 지난주 최고의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요? 1. 테슬라(NASDAQ:TSLA)의 주식은 실적 호조와 전반적인 시장 강세로 인해 21.97% 상승했다.

테슬라와 리 오토는 지난주 최고 성과를 보여준 10개 대형주 중 일부 (10월 21일-10월 25일)

Equities

Markets

SBUX

화요일, 미국 시장은 혼조세로 마감했다. 다우존스 산업평균지수는 거의 변동 없이 42,924.89로 마감했으며, S&amp;P 500은 0.05% 소폭 하락하여 5,851.20으로 마감했다. 반면, 나스닥은 0.2% 상승하여 18,573.13으로 마감했다.

화요일 주목받은 주식 5종목: 트럼프 미디어, 맥도날드, 스타벅스, 필립 모리스 및 테슬라

Previews

Tech

ABBV

AGYS

ASML

BJRI

CHKP

CHTR

CMCSA

DECK

GATX

GOOG

GOOGL

JNPR

NFLX

NXPI

ODFL

ORLY

SKYW

SPOT

VRSN

S&amp;P 500 기업들 중 약 14%가 6월 분기 실적을 발표했으며, 더 넓은 지수를 구성하는 기업들의 혼합 실적 성장률은 여전히 ​​양호하다. 이번 주에는 기술 보고 시즌이 공식적으로 시작될 것이며, 이는 최근 주에 가파른 하락세를 보인 시장의 향방을 잠재적으로 결정할 수 있다.

테슬라, 알파벳, GM 및 포드가 이번 주 실적 발표 주도하며 상승세 유지 위해 고군분투

Philip Morris International Inc Common Stock

Philip Morris International Inc

Plasmatech Inc

Innovator U.S. Equity Power Buffer ETF - March

PREMIER INVESTMENTS LTD by Premier Investments Ltd.

Premier Investments Ltd

Powell Max Limited - Class A Ordinary Shares

Powell Max Ltd

Innovator U.S. Equity Power Buffer ETF - May

Pharmala Biotech Holdings Inc

PROMOTORA AMBIENTAL SAB B by Promotora Ambiental SAB de CV

Promotora Ambiental SAB de CV

PEMBINA PPLNE PFD A SER 7 by Pembina Pipeline Corp.

Pembina Pipeline Corp

PIMCO Mortgage-Backed Securities Active Exchange-Traded Fund

PMB AEROSPACE CORP by PMB Aerospace Corporation

PMB Aerospace Corp

PharmaCyte Biotech Inc

PELOTON MINERALS CORP by Peloton Minerals Corporation

Peloton Minerals Corp

PT MERDEKA COPPER GLD TBK by PT MERDEKA COPPER GOLD TBK

PT Merdeka Copper Gold Tbk

Prospector Metals Corp

PROSPECTOR METALS CORP by PROSPECTOR METALS CORP.

Pro Medicus Ltd

Psychemedics Corp.

PSYCHEMEDICS CORP NEW by Psychemedics Corp.

Psychemedics Corp

PRO MEDICUS LTD U/ADR by Pro Medicus, Ltd.

PT MITRA ADIPERKASA TBK by Pt Mitra Adiperkasa Tbk

PT Mitra Adiperkasa Tbk

PT MITRA ADIPERKASA S/ADR by Pt Mitra Adiperkasa Tbk

PACE MEDICAL INC by Pace Medical, Inc.

PLATEAU MINERAL DEV INC by Plateau Mineral Development, Inc.

Plateau Mineral Development Inc

Sonoran Desert Copper Corp

SONORAN DESERT COPPER CP by SONORAN DESERT COPPER CORP

PHARMA FOODS INTL CO by Pharma Foods International Co., Ltd.

Pharma Foods International Co Ltd

PM&E Inc

Primech Holdings Ltd

PREDICTMEDIX AI INC by PREDICTMEDIX AI INC.

Predictmedix AI Inc

PATRIOT BATTERY METALS by PATRIOT BATTERY METALS INC

Patriot Battery Metals Inc

PIMCO Municipal Income Fund

PGIM Rock ETF Trust PGIM S&P 500 Max Buffer ETF - February

Priveterra Acquisition Corp II Ordinary Shares - Class A

Priveterra Acquisition Corp II

Priveterra Acquisition Corp II Units (1 Ord Class A & 1/2 War)

Priveterra Acquisition Corp II Warrants (02/12/2025)

Perth Mint Gold Token

Perpetual Energy Inc

PRIME MERIDIAN HLDG CO by Prime Meridian Holding Co.

Prime Meridian Holding Co

PERFECT MED HLTH U/ADR by PERFECT MED HEALTH MGMT LTD.

POLOMAR HEALTH SVCS INC by Polomar Health Services, Inc.

Polomar Health Services Inc

PLASMA INNOVATIVE INC by PLASMA INNOVATIVE INC.

Plasma Innovative Inc

PGIM ETF Trust PGIM Municipal Income Opportunities ETF

PMI GROUP INC NEW by PMI Group, Inc. (The)

PMI Group Inc

PT MULTI INDOCITRA ORD by PT Multi Indocitra Tbk

PGIM Rock ETF Trust PGIM S&P 500 Max Buffer ETF - January

PT Merck Tbk

Playmaker Capital Inc Ordinary Shares

PINKMONKEY.COM INC by PinkMonkey.com, Inc.

PinkMonkey.com Inc

Pimco Municipal Income Fund II Common Shares of Beneficial Interest

PIMCO Municipal Income Fund II

Putnam Managed Municipal Income Trust Common Stock

Putnam Managed Municipal Income Trust

PUMA AG RUDOLF DASSLER SP by Puma AG Rudolf Dassler Sport

Puma SE

PEMBINA PIPELINE CORP PFD by Pembina Pipeline Corp.

Pampa Metals Corp Ordinary Shares

PAMPA METALS CORP by Pampa Metals Corporation

Pampa Metals Corp

PREMIUM EXPL INC by Premium Exploration, Inc.

Premium Exploration Inc

BlackRock ETF Trust iShares Prime Money Market ETF

PREMIUM GROUP CO LTD by PREMIUM GROUP CO LTD.

Premium Group Co Ltd

Precious Metals and Mining Trust

ProMIS Neurosciences Inc. - Common Shares

ProMIS Neurosciences Inc

Perfect Moment Ltd

PERSEUS MINING LTD ORD by Perseus Mining Ltd

Perseus Mining Ltd

Putnam Municipal Opportunities Trust Common Stock

Putnam Municipal Opportunities Trust

Harbour Energy PLC

Prismo Metals Inc

Polychain Monsters

PRISMONE GROUP INC by PrismOne Group, Inc.

PREMIER PRODUCTS GROUP by Premier Products Group, Inc.

Premier Products Group Inc

Primaris REIT

POP MART INTL UNSP/ADR by Pop Mart International Group Limited

Pop Mart International Group Ltd

PROTEOME SCIENCES PLC by Proteome Sciences PLC

Proteome Sciences PLC

PRIMAL SOLUTIONS INC by Primal Solutions, Inc.

Primal Solutions Inc

PennyMac Mortgage Investment Trust Common Shares of Beneficial Interest

PennyMac Mortgage Investment Trust

PACIFIC METALS CO LTD by Pacific Metals Co., Ltd.

Pacific Metals Co Ltd

PRECIOUS MTLS BULLION TR by Precious Metals Bullion Trust

CPI Card Group Inc

PennyMac Mortgage Investment Trust 8.50% Senior Notes due 2028

PennyMac Mortgage Investment Trust 9.00% Senior Notes due 2030

PLAYMATES TOYS LTD ORD by Playmates Toys Ltd.

Playmates Toys Ltd

PennyMac Mortgage Investment Trust 8.125% Series A Fixed-to-Floating Rate Cumulative Redeemable Preferred Shares of Beneficial Interest

PennyMac Mortgage Investment Trust 8.00% Series B Fixed-to-Floating Rate Cumulative Redeemable Preferred Shares of Beneficial Interest

PennyMac Mortgage Investment Trust 6.75% Series C Cumulative Redeemable Preferred Shares of Beneficial Interest

PMV CONSUMER ACQ CORP A by PMV Consumer Acquisition Corp.

PMV CONSUMER ACQ A NEW by PMV Consumer Acquisition Corp.

PMV Consumer Acquisition Corp

PMV Consumer Acquisition Corp Warrants (31/08/2027)

PMV Pharmaceuticals Inc

PIMCO Municipal Income Fund III Common Shares of Beneficial Interest

PIMCO Municipal Income Fund III

SYNTARA LTD by SYNTARA LTD.

Primix Corp

Boab Metals Ltd

Investors with a lot of money to spend have taken a bullish stance on Philip Morris Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with PM, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 31 uncommon options trades for Philip Morris Intl.
This isn't normal.
The overall sentiment of these big-money traders is split between 35% bullish and 25%, bearish.
Out of all of the special options we uncovered, 12 are puts, for a total amount of $399,644, and 19 are calls, for a total amount of $814,288.
<h3>Predicted Price Range</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $85.0 to $165.0 for Philip Morris Intl during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Philip Morris Intl's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Philip Morris Intl's whale activity within a strike price range from $85.0 to $165.0 in the last 30 days. 
<h3>Philip Morris Intl 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740168990_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>PM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$1.15</td>
<td>$1.0</td>
<td>$1.05</td>
<td>$160.00</td>
<td>$76.6K</td>
<td>1.0K</td>
<td align="right">897</td>
</tr>
<tr>
<td>PM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$1.0</td>
<td>$0.8</td>
<td>$0.8</td>
<td>$145.00</td>
<td>$64.1K</td>
<td>709</td>
<td align="right">927</td>
</tr>
<tr>
<td>PM</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$10.0</td>
<td>$9.6</td>
<td>$9.8</td>
<td>$150.00</td>
<td>$58.8K</td>
<td>1.4K</td>
<td align="right">4</td>
</tr>
<tr>
<td>PM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/21/25</td>
<td>$7.2</td>
<td>$6.8</td>
<td>$7.1</td>
<td>$165.00</td>
<td>$56.0K</td>
<td>1</td>
<td align="right">0</td>
</tr>
<tr>
<td>PM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$9.3</td>
<td>$9.1</td>
<td>$9.3</td>
<td>$145.00</td>
<td>$55.8K</td>
<td>2.1K</td>
<td align="right">87</td>
</tr>
</tbody>
</table>

<h3>About Philip Morris Intl</h3>
Created from the international operations of Altria in 2008, Philip Morris International sells cigarettes and reduced-risk products, including heatsticks, vapes, and oral nicotine offerings primarily outside of the US. With the 2023 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches primarily in the US and Scandinavia, PMI has not only diversified away from smokeable products but also gained a toehold into the US to sell its iQOS heated tobacco product.
Having examined the options trading patterns of Philip Morris Intl, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Where Is Philip Morris Intl Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 3,491,113, the PM's price is up by 1.53%, now at $153.88. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 61 days.</li>
</ul>
<h3>What The Experts Say On Philip Morris Intl</h3>
Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $146.67.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from UBS persists with their Sell rating on Philip Morris Intl, maintaining a target price of $120. 
&#x2A; Consistent in their evaluation, an analyst from JP Morgan keeps a Overweight rating on Philip Morris Intl with a target price of $160. 
&#x2A; An analyst from Stifel persists with their Buy rating on Philip Morris Intl, maintaining a target price of $160. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Philip Morris Intl with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Options

Decoding Philip Morris Intl's Options Activity: What's the Big Picture?

2025 Full-Year Forecast
PMI reaffirms its 2025 full-year reported diluted EPS forecast, announced on February 6th, of $6.55 to $6.68. Excluding a total 2025 adjustment of $0.49 per share, the forecast range for adjusted diluted EPS of $7.04 - $7.17 represents a projected increase of 7.2% to 9.1% versus $6.57 in 2024. Excluding an adverse currency impact, at then prevailing exchange rates, of $0.22 per share, this represents growth of 10.5% to 12.5%, as shown below.
The assumptions underlying this forecast remain unchanged versus those communicated by PMI in its earnings release of February 6, 2025.
Factors described in the Forward-Looking and Cautionary Statements section of this release represent continuing risks to these projections.
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="9" rowspan="1">Full-Year</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="3" rowspan="1">2025 Forecast</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">2024</td>
<td colspan="3" rowspan="1">Growth</td>
<td>&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Reported Diluted EPS</td>
<td colspan="1" rowspan="1">$6.55</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">$6.68</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$ 4.52</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjustments:</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Restructuring charges</td>
<td colspan="3" rowspan="1">—</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">0.10</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Impairment of goodwill and other intangibles</td>
<td colspan="3" rowspan="1">—</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">0.01</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Amortization of intangibles(1)</td>
<td colspan="3" rowspan="1">0.49</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">0.40</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Loss on sale of Vectura Group</td>
<td colspan="3" rowspan="1">—</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">0.13</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Egypt sales tax charge</td>
<td colspan="3" rowspan="1">—</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">0.03</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Megapolis localization tax impact</td>
<td colspan="3" rowspan="1">—</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">0.05</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Income tax impact associated with Swedish Match AB financing</td>
<td colspan="3" rowspan="1">—</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">0.14</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Impairment related to the RBH equity investment</td>
<td colspan="3" rowspan="1">—</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">1.49</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Fair value adjustment for equity security investments</td>
<td colspan="3" rowspan="1">—</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">(0.27)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Tax items</td>
<td colspan="3" rowspan="1">—</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">(0.03)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Total Adjustments</td>
<td colspan="3" rowspan="1">0.49</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">2.05</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted Diluted EPS</td>
<td colspan="1" rowspan="1">$7.04</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">$7.17</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$ 6.57</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">7.2%</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">9.1%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Less: Currency</td>
<td colspan="3" rowspan="1">(0.22)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted Diluted EPS, excluding currency</td>
<td colspan="1" rowspan="1">$7.26</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">$7.39</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$ 6.57</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">10.5%</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">12.5%</td>
</tr>
<tr>
<td colspan="10" rowspan="1">(1) See forecast assumptions section in Q4'24 Earnings Release for details</td>
</tr>
</tbody>
</table>
</figure>

Guidance

Philip Morris International Sees FY25 Adj. EPS $7.04-$7.17 Vs $7.03 Est.

JP Morgan analyst Jared Dinges maintains Philip Morris Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) with a Overweight and raises the price target from $145 to $160.

Price Target

Analyst Ratings

JP Morgan Maintains Overweight on Philip Morris Intl, Raises Price Target to $160

ADBE

AMZN

DASH

INTU

SCHW

Viking Global Investors' Latest 13F Filing Reveals Increased Stakes In JPMorgan Chase By 7.47M Shares, Bank of America By 24.72M, Charles Schwab By 14.66M, Intuit By 1.72M Shares, DoorDash By 4.95M, Alphabet By 3.66M, Netflix By 502.3K, Starbucks By 5.34M, CSX By 14.67M; Decreased Stakes In US Bancorp By 24.45M Shares, Philip Morris By 5.09M, Amazon By 2.61M, Adobe By 1.23M, Progressive By 2.17M, Sherwin-Williams By 618K, UnitedHealth Group By 438.8K

Investors with a lot of money to spend have taken a bullish stance on Philip Morris Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>).
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with PM, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 14 options trades for Philip Morris Intl.
This isn't normal.
The overall sentiment of these big-money traders is split between 64% bullish and 28%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $89,320, and 13, calls, for a total amount of $626,290.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $100.0 to $150.0 for Philip Morris Intl during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Philip Morris Intl stands at 1467.3, with a total volume reaching 1,534.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Philip Morris Intl, situated within the strike price corridor from $100.0 to $150.0, throughout the last 30 days.
<h3>Philip Morris Intl Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739560524_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>PM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/14/25</td>
<td>$14.1</td>
<td>$14.0</td>
<td>$14.1</td>
<td>$137.00</td>
<td>$141.0K</td>
<td>155</td>
<td align="right">101</td>
</tr>
<tr>
<td>PM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$11.8</td>
<td>$11.5</td>
<td>$11.6</td>
<td>$150.00</td>
<td>$89.3K</td>
<td>121</td>
<td align="right">77</td>
</tr>
<tr>
<td>PM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$16.6</td>
<td>$16.3</td>
<td>$16.6</td>
<td>$150.00</td>
<td>$79.6K</td>
<td>2</td>
<td align="right">59</td>
</tr>
<tr>
<td>PM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$7.5</td>
<td>$7.4</td>
<td>$7.4</td>
<td>$145.00</td>
<td>$62.9K</td>
<td>2.1K</td>
<td align="right">90</td>
</tr>
<tr>
<td>PM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/28/25</td>
<td>$18.6</td>
<td>$18.1</td>
<td>$18.7</td>
<td>$133.00</td>
<td>$46.7K</td>
<td>32</td>
<td align="right">45</td>
</tr>
</tbody>
</table>

<h3>About Philip Morris Intl</h3>
Created from the international operations of Altria in 2008, Philip Morris International sells cigarettes and reduced-risk products, including heatsticks, vapes, and oral nicotine offerings primarily outside of the US. With the 2022 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches primarily in the US and Scandinavia, PMI has not only diversified away from smokeable products but also gained a toehold into the US to sell its iQOS heatsticks.
<h3>Where Is Philip Morris Intl Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 2,242,140, with PM's price up by 1.32%, positioned at $151.15.</li>
<li>RSI indicators show the stock to be may be overbought.</li>
<li>Earnings announcement expected in 68 days.</li>
</ul>
<h3>Professional Analyst Ratings for Philip Morris Intl</h3>
In the last month, 3 experts released ratings on this stock with an average target price of $140.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from UBS persists with their Sell rating on Philip Morris Intl, maintaining a target price of $120. 
&#x2A; Maintaining their stance, an analyst from Stifel continues to hold a Buy rating for Philip Morris Intl, targeting a price of $160. 
&#x2A; In a cautious move, an analyst from Morgan Stanley downgraded its rating to Overweight, setting a price target of $140. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Philip Morris Intl with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Philip Morris Intl's Options: A Look at What the Big Money is Thinking

Philip Morris International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>), one of the largest tobacco companies in the world, has undergone a dramatic transformation over the past few years. As cigarette smoking continues its decades-long decline, PMI has aggressively expanded into smokeless alternatives, with Zyn &#8211; its flagship nicotine pouch brand &#8211; emerging as a major driver of growth.
Zyn's rapid adoption in the U.S. market has played a key role in PMI's resurgence. Earlier this year, the Food and Drug Administration (FDA) <a href="https://www.benzinga.com/25/01/43054519/zyn-nicotine-pouches-receive-fda-marketing-approval">authorized</a> 20 Zyn products for sale, <a href="https://www.fda.gov/news-events/press-announcements/fda-authorizes-marketing-20-zyn-nicotine-pouch-products-after-extensive-scientific-review">determining</a> that these pouches contain "substantially lower amounts of harmful constituents than cigarettes and most smokeless tobacco products." This regulatory green light reinforced Zyn's positioning as a lower-risk alternative to traditional tobacco products.
PMI's $16 billion acquisition of Swedish Match, the original manufacturer of Zyn, in 2022 has proven to be a strategic coup. The company reported shipping 238 million cans of Zyn in the U.S. that year, with projections indicating that this number will more than double in 2024. According to <a href="https://www.cnbc.com/2025/01/29/-how-zyn-helped-philip-morris-international-make-a-comeback-.html?&amp;qsearchterm=zyn">CNBC</a>, PMI has committed over $832 million to expand Zyn's production capacity, including new manufacturing plants in Aurora, Colorado and Owensboro, Kentucky.
This shift aligns with PMI's <a href="https://www.pmi.com/our-progress/pmi-announces-ambition-to-become-a-more-than-two-thirds-majority-smoke-free-company-by-2030">broader corporate strategy</a>: by 2030, the company aims for two-thirds of its revenue to come from smoke-free products, with an eventual goal of moving entirely away from cigarettes. As Goldman Sachs senior analyst Bonnie Herzog told CNBC, "The beauty of this transformation is that they're actually generating faster top-line and faster profitability given the pivot to these businesses."
With Zyn's meteoric rise, PMI has demonstrated that nicotine pouches are more than just a passing trend. They represent a scalable, profitable and consumer-friendly alternative to traditional tobacco products. The question now is: can a similar shift happen in the cannabis industry?
<h3 class="wp-block-heading">From Nicotine To Nootropics: Pouches Are Just Getting Started</h3>
While Zyn has reshaped the nicotine industry, its success is part of a broader shift in how consumers approach smokeless and discreet consumption. Pouches, as a delivery system, are gaining traction across multiple categories, including cannabinoids, caffeine and nootropics. This trend suggests that the appeal of pouches extends far beyond nicotine replacement, opening the door for new product innovations.
Nick Kenny, lead advisor at KBS Strategic Advisory, has worked closely with major tobacco companies exploring these adjacent markets. He points out that Zyn's success has fueled renewed interest in pouches as a delivery method for other substances.
"The widespread adoption of oral nicotine pouches by regulators and adult consumers has spurned renewed interest in the category as a delivery method for cannabinoids," Kenny told <a href="https://www.benzinga.com/cannabis">Benzinga</a> in an exclusive interview. "Big Tobacco [companies] are consistently looking to diversify and enhance their portfolio of offerings, and where they can leverage existing technology to differentiate, such as in the case of pouches, it's a natural adjacency to take advantage of."
Beyond nicotine, companies are expanding into new bioactive substances that fit well within the pouch format. Cannadips, a California-based company specializing in smokeless, spit-free pouches, has pioneered THC and CBD-infused alternatives to traditional oral tobacco. Co-founder Case Mandel has been at the forefront of this shift, developing pouches infused with THC, CBD, caffeine and nootropics.
"We participate in all those different categories (&#8230;) we have brands in all the different verticals," Mandel told Benzinga. "Pouches are becoming an acceptable way to consume many different things."
The appeal of pouches is rooted in their smoke-free, discreet and fast-acting nature. Unlike traditional edibles or tinctures, which must pass through the digestive system, pouches deliver active ingredients through oral absorption, leading to a quicker onset of effects. This efficiency has made them particularly attractive for consumers looking for functional products, whether for focus, energy, relaxation or mood enhancement.
Caffeine pouches have already started to take off, following a similar trajectory to nicotine pouches. Mandel notes that the market has grown significantly, with his company seeing success in partnerships like Upperdeckys, a high-dose caffeine pouch brand that has gained popularity through influencer marketing.
"We have the highest-dose caffeine pouch product on the market," Mandel said. "Every pouch is almost like an energy drink."
Meanwhile, nootropic pouches infused with compounds aimed at enhancing cognitive function have also started to gain momentum. Mandel's company has developed nootropic pouches under the Rebel brand, leveraging ingredients like Alpha-GPC and Cognizin to cater to consumers looking for performance-enhancing alternatives.
"We see that the new age of consumers want healthier products, they want to know where their ingredients are from and they want cutting-edge delivery systems," Mandel said.
With consumer behavior shifting toward discreet, functional and efficient consumption, pouches are proving to be a format with applications far beyond nicotine. The question now is whether cannabis pouches can follow the same path, carving out a substantial market segment like Zyn did in the nicotine space.
<h3 class="wp-block-heading">Can THC Pouches Follow In Zyn's Footsteps?</h3>
While nicotine and functional ingredient pouches have gained mainstream traction, cannabis-infused pouches remain a niche product. Forbes' Will Yakowicz recently <a href="https://www.forbes.com/sites/willyakowicz/2025/01/31/zyn-with-weed-cannadips-pouch-craze-hits-the-cannabis-industry/">reported</a> on the rise of THC-infused pouches, spotlighting companies like Cannadips and Juana Dips that are leading the charge in this emerging category. These companies are working to establish THC pouches as a viable segment within the cannabis industry, but the path to success is far from straightforward.
While Mandel sees major potential, he acknowledges the significant barriers to scaling THC pouches. "We believe THC pouches are going to be a big market in the future," he said. "But due to the incredibly high capital expenditure costs of pouching machines and intellectual property –and this really poorly fragmented state-by-state regulatory model due to lack of federal reform– it's been very hard for us or anyone else to get significant traction in the THC pouch space."
Unlike nicotine pouches, which can be sold nationwide in convenience stores, THC-infused pouches are limited by the patchwork of U.S. cannabis laws. Without federal legalization, each state enforces its own licensing and distribution rules, creating barriers to scaling production and streamlining sales.
Without centralized production and wider distribution, THC pouches won't easily compete with dominant cannabis formats like flower and vapes.
"At some point, we, as well as others, will be able to have a factory in one location, provide product to the country and get it for a price that consumers can afford and can build into their daily routine versus like a novelty," Mandel said.
Price is another major factor. Cannabis pouches are significantly more expensive than nicotine pouches, making it difficult to drive widespread adoption. While a can of nicotine pouches typically costs around $6, THC pouches can be three to four times more expensive due to taxes, compliance costs and limited production scalability.
"When consumers see a circular can, especially if they use Rogue or any of these products, they expect the product to be the same price or close to it," Mandel said. "No one&#8217;s going to switch from a $6 product to a $30 product and use it at the same frequency. It's just really hard."
For THC pouches to reach mainstream consumers, Mandel argues that the industry will need some level of federal reform to reduce costs and streamline production.
"Really, in my opinion, it&#8217;s going to have to be about commoditization," he said. "Until we can normalize the price of a THC pouch to be at least close to a nicotine pouch, it will be hard for it to be anything more than a novelty product that people use occasionally rather than incorporating into their daily routine."
Despite these challenges, companies like Cannadips are focusing on regions with strong smokeless tobacco traditions to drive early adoption. The company has launched in Arkansas, Missouri and Kentucky, among others, where dip products are already popular, in an effort to establish pouches as a daily-use product rather than a novelty.
"We&#8217;re looking at areas of strength where we can put our attention to and really show that this isn't just a novelty product," Mandel said. "This is a product that people are building into their daily lives."
For THC pouches to reach mass-market success, pricing, regulations and consumer awareness will need to improve. If those barriers are addressed, they could become a major category within the cannabis industry. The next question is whether Big Tobacco and large cannabis operators will step in to accelerate growth—or if THC pouches will remain a niche product.
<h3 class="wp-block-heading">Who Will Fund The Rise Of Cannabis Pouches?</h3>
As cannabis pouches attempt to carve out a foothold in the market, the key question remains: Will large-scale industry players, whether Big Tobacco or major cannabis operators, step in to accelerate their adoption?
Nick Kenny believes tobacco companies are closely monitoring the category but will only invest if they see clear market potential and broad distribution opportunities. "Big Tobacco [companies] have the desire and ability to make the category successful. However, they will only do so if they can deliver a product that can differentiate in experience and attain widespread distribution," he said.
Kenny also noted that consumer adoption and regulatory barriers will both play critical roles in determining the success of THC pouches. Unlike nicotine pouches, which benefit from nationwide distribution, THC pouches face restrictions due to fragmented state-by-state cannabis laws, making it difficult for companies to scale efficiently.
Despite these challenges, Case Mandel sees long-term potential. "We created the category. We&#8217;ve been doing this now for nine years," he said. "We&#8217;ve solved a lot of the issues when it comes to delivery of cannabinoids."
Still, affordability remains a major hurdle. Without economies of scale, THC pouches are significantly more expensive than nicotine pouches, limiting mass adoption.
"Recreational cannabis is really expensive, and it's really expensive compared to traditional [illicit] markets in a lot of states," Mandel said.
One potential avenue for wider availability is hemp-derived THC pouches, which fall under the 2018 Farm Bill. However, Mandel points out that regulations on THC content per pouch make them less competitive than edibles, vapes and drinks. "Because a pouch is only 500 milligrams, you&#8217;re looking at a milligram and a half of THC per pouch," he explained.
Rather than trying to force national expansion too early, Mandel's strategy is to focus on regions with strong smokeless tobacco traditions, where dip users may be more likely to embrace the format.
"We&#8217;re kind of looking at areas of strength where we can put our attention to and really show, ‘Hey, this isn't just a novelty product. This is a product that people are building into their daily life,'" he said.
The future of cannabis pouches will depend on major industry investment, evolving regulations, and consumer demand. If a major player—either in cannabis or tobacco—commits to mass production and distribution, the market could scale quickly.
For now, THC pouches remain a niche product, but the potential is there. If a dominant player enters the space, cannabis pouches could redefine consumption—just as Zyn did with nicotine.
Lead image via Shutterstock

Cannabis

Health Care

Exclusives

Interview

Zyn Changed Nicotine Forever - Are Cannabis Pouches The Next Big Thing?

Stifel analyst Matthew Smith maintains Philip Morris Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) with a Buy and raises the price target from $145 to $160.

Stifel Maintains Buy on Philip Morris Intl, Raises Price Target to $160

UBS analyst Faham Baig maintains Philip Morris Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) with a Sell and raises the price target from $105 to $120.

UBS Maintains Sell on Philip Morris Intl, Raises Price Target to $120

It's a mixed session on Wall Street, with major indices struggling for direction as investors hold their breath ahead of a key jobs report <a href="https://www.benzinga.com/markets">set for Friday morning.</a>
The S&amp;P 500 and the Nasdaq 100 edged up 0.3%, while the Dow Jones slipped 0.1% and small caps held steady.
Among the leading sectors, financial stocks outperformed after the Fed released the framework for 2025 bank stress test. The big six banks — JPMorgan Chase &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>), Bank of America Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>), Wells Fargo &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>), Goldman Sachs Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>), Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>), and Citigroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>) — all climbed more than 1%, with Citigroup surging 2.9%.
Eli Lilly Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) jumped 3.2% after topping earnings estimates, while Tapestry Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPR#NYSE">TPR</a>) surged 12% and Philip Morris International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) skyrocketed nearly 10% on strong revenue figures. In contrast, Qualcomm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) slid 4.3% on concerns over slowing smartphone demand.
Shares of Palantir Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) surged 6.5%, extending its weekly gains to 30.8%, the stock's best weekly rally since early November.
Oil prices had a volatile session. Crude initially dipped as speculation mounted over a potential Trump-Putin meeting as early as this month or next, raising hopes for possible peace talks in Ukraine. Prices rebounded after the U.S. Treasury imposed sanctions on Iran's oil network.
Gold softened, dropping 0.6% from record highs and snapping a five-session winning streak.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) remained stable, hovering just below $97,000.
<h2 class="wp-block-heading">Thursday&#8217;s Performance In Major US Indices, ETFs</h2>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %chg</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>21,742.18</td>
<td>0.4%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>6,082.15</td>
<td>0.3%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,316.14</td>
<td>0.0%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>44,811.50</td>
<td>-0.1%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 1:00 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent020325&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)&nbsp;rose 0.3% to $605.83.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) eased 0.2% to $447.73.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;inched 0.3% up to $528.47.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) flattened at $229.55.</li>
<li>The&nbsp;Financial Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>) outperformed, up 1.6%; the&nbsp;Energy Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) lagged, down 1.7%.</li>
</ul>
<h3 class="wp-block-heading">Thursday&#8217;s Stock Movers</h3>
Stocks reacting to corporate earnings, ordered by market capitalization, are:
<ul>
<li>Eli Lilly &amp; Co.: up 3.11%</li>
<li>Linde Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LIN#NYSE">LIN</a>): up 0.34%</li>
<li>Philip Morris International Inc.: up 9.97%</li>
<li>Honeywell International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HON#NASDAQ">HON</a>): down 5.33%</li>
<li>ConocoPhillips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COP#NYSE">COP</a>): down 0.71%</li>
<li>Hilton Worldwide Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLT#NYSE">HLT</a>): up 4.65%</li>
<li>Bristol-Myers Squibb Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>): down 2.04%</li>
<li>Intercontinental Exchange Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICE#NYSE">ICE</a>): up 4.95%</li>
<li>IQVIA Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IQV#NYSE">IQV</a>): up 2.95%</li>
<li>Yum! Brands Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUM#NYSE">YUM</a>): up 8.49%</li>
<li>Hershey Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HSY#NYSE">HSY</a>): up 5.16%</li>
<li>McKesson Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCK#NYSE">MCK</a>): down 2.56%</li>
<li>Qualcomm Inc.: down 4.41%</li>
<li>Molina Healthcare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOH#NYSE">MOH</a>): down 8.68%</li>
<li>O&#8217;Reilly Automotive Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORLY#NASDAQ">ORLY</a>): down 1.87%</li>
<li>MetLife Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MET#NYSE">MET</a>): down 1.39%</li>
<li>Cognizant Technology Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTSH#NASDAQ">CTSH</a>): up 3.64%</li>
<li>Corteva Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTVA#NYSE">CTVA</a>): down 3.92%</li>
<li>Allstate Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALL#NYSE">ALL</a>): down 0.07%</li>
<li>Skyworks Solutions Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWKS#NASDAQ">SWKS</a>): down 23.74%</li>
<li>Aflac Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AFL#NYSE">AFL</a>): down 3.64%</li>
<li>Align Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGN#NASDAQ">ALGN</a>): down 0.66%</li>
<li>Equifax Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>): down 6.24%</li>
<li>Zimmer Biomet Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZBH#NYSE">ZBH</a>): down 3.02%</li>
<li>Aptiv Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APTV#NYSE">APTV</a>): up 4.18%</li>
<li>Air Products &amp; Chemicals Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APD#NYSE">APD</a>): down 1.75%</li>
<li>Kellanova (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/K#NYSE">K</a>): up 0.12%</li>
<li>Ford Motor Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>): down 6.74%</li>
</ul>
Stocks reporting after the close include: 
<ul>
<li>Amazon.com Inc. </li>
<li>Illumina Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILMN#NASDAQ">ILMN</a>)</li>
<li>Fortinet Inc.</li>
<li>Expedia Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXPE#NASDAQ">EXPE</a>)</li>
<li>Take-Two Interactive Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTWO#NASDAQ">TTWO</a>)</li>
<li>Monolithic Power Systems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MPWR#NASDAQ">MPWR</a>)</li>
<li>Pinterest Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PINS#NYSE">PINS</a>)</li>
<li>SS&amp;C Technologies Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSNC#NASDAQ">SSNC</a>)</li>
<li>Principal Financial Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFG#NASDAQ">PFG</a>)</li>
<li>Mettler-Toledo International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTD#NYSE">MTD</a>)</li>
<li>AptarGroup Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATR#NYSE">ATR</a>)</li>
<li>Post Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/POST#NYSE">POST</a>)</li>
<li>Mohawk Industries Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MHK#NYSE">MHK</a>)</li>
<li>Boyd Gaming Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BYD#NYSE">BYD</a>)</li>
<li>Encompass Health Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EHC#NYSE">EHC</a>)</li>
<li>VeriSign Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRSN#NASDAQ">VRSN</a>)</li>
<li>Cloudflare Inc. </li>
<li>Skechers USA Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKX#NYSE">SKX</a>)</li>
<li>Affirm Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>)</li>
<li>Elf Beauty Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>)</li>
</ul>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43534297/january-jobs-report-preview-speculators-bet-on-strong-payroll-surge-yet-economists-predict-a-different-picture">January Jobs Report Preview: Speculators Bet On Strong Payroll Surge, Yet Economists Predict A Different Picture</a></li>
</ul>
Photo via Shutterstock.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Comments

Philip Morris Intl

뉴스

파트너 / 기고자

벤징가 글로벌